Exploring Novel Protein Degraders in Degrader-Antibody-Conjugates

By | 18 November 2025
  • Leveraging targeted protein degradation to expand therapeutic reach
  • Differentiated MOA compared to existing ADC payloads
  • Designing linkers to maximize therapeutic window